. Main-occupation and . No, %) Public sector employee 930

S. Gruskin and N. Daniels, Process Is the Point, American Journal of Public Health, vol.98, issue.9, pp.1573-1577, 2008.
DOI : 10.2105/AJPH.2007.123182

C. Murray and J. Frenk, World Health Report 2000: a step towards evidence-based health policy, The Lancet, vol.357, issue.9269, pp.1698-1700, 2001.
DOI : 10.1016/S0140-6736(00)04826-1

M. Ezzati, S. Hoorn, A. Rodgers, A. Lopez, C. Mathers et al., Estimates of global and regional potentil health gains from reducing muliple major risk factors, The Lancet, vol.362, issue.9380, pp.271-280, 2003.
DOI : 10.1016/S0140-6736(03)13968-2

A. Lopez, C. Mathers, M. Ezzati, D. Jamison, and C. Murray, Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data, The Lancet, vol.367, issue.9524, pp.1747-1757, 2006.
DOI : 10.1016/S0140-6736(06)68770-9

C. Murray, Towards good practice for health statistics: lessons from the Millennium Development Goal health indicators, The Lancet, vol.369, issue.9564, pp.862-873, 2007.
DOI : 10.1016/S0140-6736(07)60415-2

P. Berman, National Health Accounts in Developing Countries: Appropriate Methods and Recent Applications, Health Economics, vol.6, issue.1, pp.11-30, 1997.
DOI : 10.1002/(SICI)1099-1050(199701)6:1<11::AID-HEC238>3.0.CO;2-7

T. Powell-jackson and A. Mills, A review of health resource tracking in developing countries, Health Policy and Planning, vol.22, issue.6, pp.353-362, 2007.
DOI : 10.1093/heapol/czm024

J. Bobadilla, P. Cowley, P. Musgrove, and H. Saxenian, Design, content and financing of an essential national package of health services. Bull World Health Organ, pp.653-662, 1994.

D. Evans, T. Adam, T. Edejer, S. Lim, A. Cassels et al., Time to reassess strategies for improving health in developing countries, BMJ, vol.331, issue.7525, pp.3311133-1136, 2005.
DOI : 10.1136/bmj.331.7525.1133

E. Gakidou, S. Oza, C. Vidal-fuertes, A. Li, D. Lee et al., Improving Child Survival Through Environmental and Nutritional Interventions, JAMA, vol.298, issue.16, pp.2981876-1887, 2007.
DOI : 10.1001/jama.298.16.1876

R. Baltussen, E. Stolk, D. Chisholm, and M. Aikins, Towards a multi-criteria approach for priority setting: an application to Ghana, Health Economics, vol.3, issue.7, pp.689-696, 2006.
DOI : 10.1002/hec.1092
URL : http://repository.ubn.ru.nl/bitstream/2066/51079/1/51079.pdf

E. Makundi, L. Kapiriri, and O. Norheim, Combining evidence and values in priority setting: testing the balance sheet method in a low-income country, BMC Health Services Research, vol.15, issue.7, p.152, 2007.
DOI : 10.1002/hec.1092

L. Kapiriri, O. Norheim, and D. Martin, Fairness and accountability for reasonableness. Do the views of priority setting decision makers differ across health systems and levels of decision making?, Social Science & Medicine, vol.68, issue.4, pp.766-773, 2009.
DOI : 10.1016/j.socscimed.2008.11.011

P. Musgrove, R. Zeramdini, and G. Carrin, Basic patterns in national health expenditure. Bull World Health Organ, pp.134-142, 2002.

W. Yip and P. Berman, Targeted health insurance in a low income country and its impact on access and equity in access: Egypt's school health insurance, Health Economics, vol.30, issue.3, pp.207-220, 2001.
DOI : 10.1002/hec.589

R. Ellis, D. Mcinnes, and E. Stephenson, Inpatient and outpatient health care demand in Cairo, Egypt, Health Economics, vol.2, issue.3, pp.183-200, 1994.
DOI : 10.1002/hec.4730030307

S. Fouad, Egypt National Health Accounts Bethesda, MD: The Partners for Health Reformplus Project, pp.1-97, 2001.

D. Pritchard, Sustainability of USAID-Financed utility Infrastructure Activities in Egypt. USAID, pp.1-21, 2004.

R. Morgenstern, J. Shih, and S. Sessions, Comparative risk assessment: an international comparison of methodologies and results, Journal of Hazardous Materials, vol.78, issue.1-3, pp.19-39, 2000.
DOI : 10.1016/S0304-3894(00)00215-6

W. Bank, Arab Republic of Egypt Cost Assessment of Environmental Degradation The World Bank, pp.1-37

C. Frank, M. Mohamed, G. Strickland, D. Lavanchy, R. Arthur et al., The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt, The Lancet, vol.355, issue.9207, pp.355887-891, 2000.
DOI : 10.1016/S0140-6736(99)06527-7

M. Mohamed, I. Bakr, M. El-hoseiny, N. Arafa, A. Hassan et al., HCV-related morbidity in a rural community of Egypt, J Med Virol, issue.9, pp.781185-1189, 2006.

M. Schwarzinger, S. Dewedar, C. Rekacewicz, A. Elaziz, K. Fontanet et al., Chronic hepatitis C virus infection: Does it really impact health-related quality of life? A study in rural Egypt, Hepatology, vol.362, issue.6, pp.401434-1441, 2004.
DOI : 10.1002/hep.20468
URL : https://hal.archives-ouvertes.fr/inserm-00636181

M. Ghany, D. Strader, D. Thomas, and L. Seeff, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, vol.11, issue.Suppl 5, pp.1335-1374, 2009.
DOI : 10.1002/hep.22759

E. Makhzangy, H. Esmat, G. Said, M. Elraziky, M. Shouman et al., Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4, Journal of Medical Virology, vol.140, issue.9, pp.811576-1583, 2009.
DOI : 10.1002/jmv.21570

N. Antaki, A. Craxi, S. Kamal, R. Moucari, S. Van-der-merwe et al., The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report, Liver International, vol.30, issue.3, pp.342-355, 2010.
DOI : 10.1111/j.1478-3231.2009.02188.x

R. Smith, The Discrete-choice Willingness-to-pay Question Format in Health Economics:, Medical Decision Making, vol.70, issue.4, pp.194-206, 2000.
DOI : 10.1017/CBO9780511809477

S. Luchini, C. Protiere, and J. Moatti, Eliciting several willingness to pay in a single contingent valuation survey: application to health care, Health Economics, vol.5, issue.2, pp.51-64, 2003.
DOI : 10.1002/hec.703

R. Heinzen and J. Bridges, Comparison of four contingent valuation methods to estimate the economic value of a pneumococcal vaccine in Bangladesh, International Journal of Technology Assessment in Health Care, vol.10, issue.04, pp.481-487, 2008.
DOI : 10.1002/hec.568

P. Corso, J. Hammitt, and J. Graham, Valuing mortality-risk reduction: using visual aids to improve the validity of contingent valuation, Journal of Risk and Uncertainty, vol.23, issue.2, pp.165-184, 2001.
DOI : 10.1023/A:1011184119153

M. Stewart, On Least Squares Estimation when the Dependent Variable is Grouped, The Review of Economic Studies, vol.50, issue.4, pp.737-753, 1983.
DOI : 10.2307/2297773
URL : http://dataspace.princeton.edu/jspui/bitstream/88435/dsp01j9602061c/1/159.pdf

J. Kruskal and R. Shepard, A nonmetric variety of linear factor analysis, Psychometrika, vol.19, issue.2, pp.123-157, 1974.
DOI : 10.1007/BF02291465

S. Brams, P. Fishburn, K. Arrow, A. Sen, and K. Suzumura, Voting Procedures In Handbook of Social Choice and Welfare, 2002.

F. El-zanaty and W. A. , Egypt Demographic and Health Survey Egypt: Ministry of Health and Population, National Population Council, El- Zanaty and Associates, and ORC Macro, Cairo, vol.364, 2005.

N. Bronfman and L. Cifuentes, Risk Perception in a Developing Country: The Case of Chile, Risk Analysis, vol.15, issue.6, pp.1271-1285, 2003.
DOI : 10.1111/j.0272-4332.2003.00400.x

M. Siegrist, C. Keller, and H. Kiers, A New Look at the Psychometric Paradigm of Perception of Hazards, Risk Analysis, vol.28, issue.1, pp.211-222, 2005.
DOI : 10.1348/000711000159132

C. Hezode, N. Forestier, G. Dusheiko, P. Ferenci, S. Pol et al., Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection, New England Journal of Medicine, vol.360, issue.18, pp.3601839-1850, 2009.
DOI : 10.1056/NEJMoa0807650
URL : https://hal.archives-ouvertes.fr/inserm-00385235

J. Mchutchison, G. Everson, S. Gordon, I. Jacobson, M. Sulkowski et al., Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection, New England Journal of Medicine, vol.360, issue.18, pp.3601827-1838, 2009.
DOI : 10.1056/NEJMoa0806104

P. Kwo, E. Lawitz, J. Mccone, E. Schiff, J. Vierling et al., Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial, The Lancet, vol.376, issue.9742, pp.376705-716, 2010.
DOI : 10.1016/S0140-6736(10)60934-8

A. Pruss-ustun and C. Corvalan, How much disease burden can be prevented by environmental interventions? Epidemiology, pp.167-178, 2007.

T. Arnesen and L. Kapiriri, Can the value choices in DALYs influence global priority-setting? Health Policy, pp.137-149, 2004.

T. Ustun, J. Rehm, S. Chatterji, S. Saxena, R. Trotter et al., Multiple-informant ranking of the disabling effects of different health conditions in 14 countries. WHO/NIH Joint Project CAR Study Group, Lancet, issue.9173, pp.354111-115, 1999.

A. Pruss-ustun, S. Bonjour, and C. Corvalan, The impact of the environment on health by country: a meta-synthesis, Environ Health, vol.7, issue.7, 2008.

F. Godlee, N. Pakenham-walsh, D. Ncayiyana, B. Cohen, and A. Packer, Can we achieve health information for all by 2015? Lancet, pp.295-300, 2004.
DOI : 10.1016/s0140-6736(04)16681-6
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.110.7144

D. Sridhar and R. Batniji, Misfinancing global health: a case for transparency in disbursements and decision making, The Lancet, vol.372, issue.9644, pp.1185-1191, 2008.
DOI : 10.1016/S0140-6736(08)61485-3

S. Moon, N. Szlezak, C. Michaud, D. Jamison, G. Keusch et al., The Global Health System: Lessons for a Stronger Institutional Framework, PLoS Medicine, vol.26, issue.9681, p.1000193, 2010.
DOI : 10.1371/journal.pmed.1000193